McKesson Corporation MCK
866.64
(2.72)
(0.31%)
as of 25 Sep
- Market cap
- $101.8B
- P/E
- 23.1×
Follow MCK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
McKesson Corporation (MCK) Net income
McKesson Corporation's net income for fiscal 2026 was $5.1B, up 46.5% from $3.5B in fiscal 2025. Over the twelve months to 30 June 2026 it was $5.3B. Over the past ten years it has ranged from −$4.3B (fiscal 2021) to $5.2B (fiscal 2017); the current reading is higher than 92% of that period. McKesson Corporation ranks 1st of 11 Medical Distribution companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2026 | $5.1B | 46.48% |
| FY2025 | $3.5B | 10.16% |
| FY2024 | $3.2B | (15.10%) |
| FY2023 | $3.7B | 189.20% |
| FY2022 | $1.3B | — |
| FY2021 | −$4.3B | — |
| FY2020 | $1.1B | 339.22% |
| FY2019 | $255.0M | (14.14%) |
| FY2018 | $297.0M | (94.24%) |
| FY2017 | $5.2B | 123.07% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $1.0B | (44.37%) |
| Mar 2026 | $1.9B | 48.40% |
| Dec 2025 | $1.3B | 7.48% |
| Sep 2025 | $1.2B | 39.95% |
| 42 more quarters | Free account |
Against its own ten years
Low −$4.3B
High $5.2B
Ten-year median
$1.9B
Current reading's percentile
92
Net income against peers
| Company | Net income |
|---|---|
| MCK McKesson Corporation | $5.3B |
| COR Cencora, Inc. compare | $2.6B |
| CAH Cardinal Health, Inc. compare | $1.7B |
| HSIC Henry Schein, Inc. compare | $426.0M |
| YI 111, Inc. Sponsored ADR compare | −$3.2M |
| AHG Akso Health Group Sponsored ADR compare | −$19.2M |
| COSM Cosmos Health Inc. compare | −$24.4M |
| FOCL FocalTherics compare | −$39.0M |
| ACH Accendra Health, Inc. compare | −$302.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on MCK
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement